Skip to main content
. 2024 Apr 25;15(4):e00686. doi: 10.14309/ctg.0000000000000686

Figure 1.

Figure 1.

NGAL expression increases in the plasma of subjects with CP. (a) NGAL measured by ELISA from the multicenter (PROCEED) study discovery set. Statistical significance was determined by a non-parametric 1-way ANOVA with Tukey's multiple comparisons correction. (b) AP/RAP and CP samples were subdivided by diabetes status and compared for plasma NGAL concentration. Statistical significance was determined by 2-way ANOVA with Tukey's multiple testing correction. (c) ROCs with AUCs of plasma NGAL comparing control vs CP and (d) AP/RAP vs CP. ***P < 0.001, ****P < 0.0001. AP, acute pancreatitis; CP, chronic pancreatitis; ELISA, enzyme-linked immunosorbent assay; NGAL, neutrophil gelatinase-associated lipocalin; RAP, recurrent acute pancreatitis.